← back to search

Jonathan Katz

Sutter Health ·
Area of research
Neurology · Cellular and Molecular Neuroscience
Research interest
Research interests include Amyotrophic Lateral Sclerosis Research, Peripheral Neuropathies and Disorders, Hereditary Neurological Disorders, and Neurogenetic and Muscular Disorders Research.
h-index
45
citations
7,819
works
152
NIH funding
primary concept
Amyotrophic lateral sclerosis
email

Recent publications

Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis
JAMA Network Open 2025cited by 15position: middledoi
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial
Journal of Neurology Neurosurgery & Psychiatry 2022cited by 65position: middledoi
A Phase 1 study of <scp>GDC</scp>‐0134, a dual leucine zipper kinase inhibitor, in <scp>ALS</scp>
Annals of Clinical and Translational Neurology 2022cited by 37position: firstdoi
A randomized <scp>placebo‐controlled</scp> phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis
Muscle & Nerve 2021cited by 113position: middledoi
Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis
New England Journal of Medicine 2020cited by 519position: middledoi
Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS
Neurology 2020cited by 200position: middledoi
Long‐term survival of participants in the <scp>CENTAUR</scp> trial of sodium phenylbutyrate‐taurursodiol in <scp>amyotrophic lateral sclerosis</scp>
Muscle & Nerve 2020cited by 176position: middledoi
Phase I clinical trial of safety of L-serine for ALS patients
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2016cited by 75position: middledoi
Randomized phase 2 trial of NP001, a novel immune regulator
Neurology Neuroimmunology & Neuroinflammation 2015cited by 96position: middledoi
Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial
The Lancet 2014cited by 265position: middledoi
NP001 regulation of macrophage activation markers in ALS: A phase I clinical and biomarker study
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2014cited by 62position: middledoi
Japanese and American ALS patient preferences regarding TIV (tracheostomy with invasive ventilation): A cross-national survey
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2014cited by 54position: middledoi
Systemic immune system alterations in early stages of Alzheimer's disease
Journal of Neuroimmunology 2013cited by 122position: middledoi
Design and Initial Results of a Multi-Phase Randomized Trial of Ceftriaxone in Amyotrophic Lateral Sclerosis
PLoS ONE 2013cited by 103position: middledoi
Genetic CJD with a novel E200G mutation in the prion protein gene and comparison with E200K mutation cases
Acta Neuropathologica Communications 2013cited by 54position: middledoi
Regional Anesthesia Improves Outcome After Distal Radius Fracture Fixation Over General Anesthesia
Journal of Orthopaedic Trauma 2012cited by 73position: middledoi

Grants

SaTC: CORE: Medium: Cryptography in a Post-Quantum Future
NSF2154705$1,000,4002022–2026PIRePORTER
CPS: Medium: Collaborative Research: Security vs. Privacy in Cyber-Physical Systems
NSF1837517$360,0002018–2023PIRePORTER
TWC: Medium: Collaborative: New Protocols and Systems for RAM-Based Secure Computation
NSF1563722$484,1962016–2021PIRePORTER
TWC: Small: Exploring Cryptographic Models and Setup Assumptions
NSF1223623$400,9452012–2016PIRePORTER
TC: Large: Collaborative Research: Practical Secure Two-Party Computation: Techniques, Tools, and Applications
NSF1111599$1,000,0002011–2018PIRePORTER
Understanding Fairness in Secure Two-Party and Multi-Party Computation
NSF0830464$277,7822008–2013PIRePORTER
Collaborative Research: CT-ISG: Efficient Cryptography Based on Lattices
NSF0716651$138,5002007–2012PIRePORTER
New Techniques for Authenticating Humans (and Other Resource-Constrained Devices)
NSF0627306$300,0002006–2011PIRePORTER
CAREER: Models and Cryptographic Protocols for Unstructured, Decentralized Systems
NSF0447075$480,0002005–2013PIRePORTER
Collaborative Research: Mitigating the Damaging Effects of Key Exposure
NSF0310751$240,0002003–2008PIRePORTER
Collaborative Research:Modeling Issues with Time-Series--Cross-Section Data
NSF0213549$111,8352002–2004PIRePORTER
Collaborative Research: Strategic Redistricting and its Political Consequences
NSF9896325$48,3331998–1999PIRePORTER
Collaborative Research: Strategic Redistricting and its Political Consequences
NSF9729899$48,3331998–1998PIRePORTER
Numerical Hydrodynamics of Gamma-Ray Bursts
NSF9416904$50,0001995–1999PIRePORTER
Research in Theoretical High Energy Astrophysics
NSF8121704$79,4001982–1984PIRePORTER
The Accretion of Mass Onto Compact Stellar Objects
NSF7815431$25,4001979–1981PIRePORTER

Frequent collaborators

Robert G. Miller · Universidade de Brasília5 papers (2013–2021)Merit Cudkowicz · Harvard University4 papers (2013–2022) · 3 papers (2013–2016)James D. Berry · Buffalo State University3 papers (2013–2022)Jonathan D. Glass · Emory University3 papers (2013–2022)Terry Heiman‐Patterson · Temple College2 papers (2014–2014)Jeffrey D. Rothstein · German Center for Neurodegenerative Diseases2 papers (2013–2022)Hiroshi Mitsumoto · Columbia University Irving Medical Center2 papers (2014–2014)Michael S. McGrath · University of California, San Francisco2 papers (2013–2014)Tahseen Mozaffar · University of California, Irvine2 papers (2014–2021)Rongzhen Zhang · Xijing Hospital2 papers (2013–2014)Ericka Simpson · University of North Carolina at Chapel Hill1 papers (2013–2013) · 1 papers (2014–2014)Catherine Lomen‐Hoerth · University of California, San Francisco1 papers (2014–2014)Stephen J. DeArmond · University of California, San Francisco1 papers (2013–2013)Todd Levine · University of Kansas1 papers (2016–2016)Catherine Madison · Dartmouth College1 papers (2013–2013) · 1 papers (2014–2014)Anthony J. Windebank · University of Massachusetts Chan Medical School1 papers (2021–2021)Leonard van den Berg · Utrecht University1 papers (2022–2022)